{"version":"1.0","provider_name":"SwedenBIO","provider_url":"https:\/\/swedenbio.se\/en\/","title":"Cyclic Therapeutics - SwedenBIO","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"YI8cfDPkmz\"><a href=\"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/\">Cyclic Therapeutics<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/swedenbio.se\/en\/medlemmar\/cyclic-therapeutics\/embed\/#?secret=YI8cfDPkmz\" width=\"600\" height=\"338\" title=\"&#8220;Cyclic Therapeutics&#8221; &#8212; SwedenBIO\" data-secret=\"YI8cfDPkmz\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/swedenbio.se\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Its proprietary platforms, EvoBind\u00a0and RareFold, enable blind de novo design of linear and cyclic peptides directly from protein sequence, without requiring target structures, binding sites, or predefined peptide lengths. The models incorporate induced fit and directed evolution in silico and expand the design space beyond the 20 natural amino acids through non-canonical residues. The platform [&hellip;]"}